IPCEF1

IPCEF1 functions as a positive regulator of cytohesin 2 (ARNO) guanine-nucleotide exchange factor (GEF) activity toward ARF6, thereby coupling growth factor signaling to membrane trafficking and cell migration. IPCEF1 binds the coiled-coil domain of cytohesin 2 through its C-terminal 121 amino acids, co-localizes with cytohesin 2 in the cytosol, and translocates with it to the plasma membrane upon EGF stimulation; this interaction enhances ARF6-GTP loading both in vitro and in vivo (PMID:12920129). IPCEF1 constitutes the C-terminal half of the CNK3/CNKSR3 scaffold protein, and knockdown of the fused CNK3/IPCEF1 protein impairs HGF-induced ARF6 activation and epithelial cell migration (PMID:22085542). Beyond its role in epithelial migration, enforced IPCEF1 expression in Th17 cells abolishes TLR2-driven migratory capacity and attenuates experimental autoimmune encephalomyelitis (PMID:34192530), and high IPCEF1 expression in papillary thyroid cancer cells induces cell cycle arrest and reduces proliferation (PMID:39513122).

1. 2003 High

   The discovery that IPCEF1 physically binds the coiled-coil domain of cytohesin 2 and enhances its GEF activity toward ARF6 established IPCEF1 as a direct positive modulator of ARF signaling, answering how cytohesin 2 catalytic output is amplified.

   Evidence Yeast two-hybrid, GST pull-down with deletion mutants, co-IP, in vitro ARF GEF assay, and in vivo ARF-GTP pull-down in mammalian cells

   PMID:12920129

   Open questions at the time

   • Structural basis of the IPCEF1–cytohesin 2 interaction is unresolved
   • Mechanism by which IPCEF1 binding enhances GEF catalytic activity is not defined
   • Whether IPCEF1 modulates cytohesin activity in a tissue-specific manner was not addressed
2. 2003 High

   Demonstrating that IPCEF1 co-localizes with cytohesin 2 in the cytosol and translocates to the plasma membrane upon EGF stimulation — dependent on the cytohesin 2 binding site — established the spatial regulation mechanism coupling receptor activation to ARF6 signaling at the membrane.

   Evidence Immunofluorescence microscopy with EGF stimulation and deletion mutant lacking cytohesin 2 binding domain

   PMID:12920129

   Open questions at the time

   • Whether IPCEF1 also functions independently of cytohesin 2 at the membrane was not tested
   • The signal that triggers IPCEF1–cytohesin 2 complex translocation (PI(3,4,5)P3 or other) was not dissected
3. 2011 High

   The finding that IPCEF1 is the C-terminal half of the CNK3/CNKSR3 scaffold protein, and that knockdown of this fused protein impairs HGF-induced ARF6 activation and cell migration, connected IPCEF1 function to a larger signaling scaffold and established its physiological relevance in epithelial cell migration.

   Evidence Molecular cloning/sequence analysis; siRNA knockdown with ARF6-GTP pull-down and migration assay in MDCK and CaCo-2 cells

   PMID:22085542

   Open questions at the time

   • Whether the IPCEF1 portion functions autonomously when separated from the CNK3 N-terminal scaffold domains is unclear
   • Signaling inputs from HGF receptor to the CNK3/IPCEF1 fusion remain unmapped
4. 2021 Medium

   Enforced IPCEF1 expression in Th17 cells abolished TLR2-driven migration and impaired EAE induction, revealing that IPCEF1 negatively regulates immune cell migration and pathogenic T cell function in an autoimmune context — extending its role beyond epithelial biology.

   Evidence Retroviral overexpression in Th17 cells; transwell migration assay; in vivo EAE model

   PMID:34192530

   Open questions at the time

   • Whether IPCEF1 acts through cytohesin 2/ARF6 in Th17 cells or through an alternative pathway was not determined
   • Loss-of-function in Th17 cells was not reported
   • Mechanism linking IPCEF1 to TLR2 signaling is unknown
5. 2024 Medium

   High IPCEF1 expression induced S/G2 cell cycle arrest and reduced proliferation and migration in papillary thyroid cancer cells, establishing a tumor-suppressive function for IPCEF1 in this cancer type.

   Evidence CCK8 proliferation assay, transwell migration assay, flow cytometry cell cycle analysis in PTC cell lines

   PMID:39513122

   Open questions at the time

   • Upstream regulators of IPCEF1 expression in PTC are unknown
   • The mechanism by which IPCEF1 induces cell cycle arrest (direct target, pathway) was not identified
   • No in vivo tumor model was used

• It remains unknown how IPCEF1 mechanistically shifts between promoting migration (via ARF6 in epithelial cells) and suppressing migration (in Th17 and cancer cells), and the structural basis by which IPCEF1 enhances cytohesin 2 catalysis has not been resolved.
• No structural model of the IPCEF1–cytohesin 2 complex exists
• Context-dependent pro- vs. anti-migratory functions are mechanistically unexplained
• Whether IPCEF1 has functions independent of cytohesin/ARF signaling remains untested